TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
RGC

Regencell Bioscience Holdings Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

6.20$ +0.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Tick rows to compare them in a chart (up to 4)

Income Statement RGC
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
3,038 2,990 3,127 3,197 3,163 0.0 0.0 0.0 0.0 0.0 0.0 –
111 111 1,208 1,227 123 – 0.0 0.0 0.6 0.8 0.7 0.4
2,927 2,879 1,920 1,970 3,040 – 0.0 0.0 -0.6 -0.8 -0.7 -0.4
– – – – – 0.2 0.4 0.4 2.5 1.6 1.1 0.9
74 74 500 512 87 0.2 0.3 0.9 5.1 4.4 2.8 2.4
1,159 1,194 1,581 1,626 1,310 0.4 0.8 1.4 7.6 6.3 4.0 3.4
340 306 339 344 272 -0.4 -0.8 -1.4 -7.6 -6.3 -4.7 -3.8
– – – 0.0 0.0 0.0 0.0 0.0 0.0 – – –
265 179 253 282 214 -0.4 -0.8 -1.3 -7.6 -6.1 -4.4 -3.6
107 73 100 111 102 0.0 0.0 -0.2 -0.2 -0.2 0.3 –
158 106 153 170 112 -0.4 -0.8 -1.3 -7.4 -5.9 -4.3 -3.6
469 391 470 512 469 -0.4 -0.8 -1.4 -7.0 -5.3 -3.6 -3.2

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?